Panacos Pharmaceuticals, Inc.
PANCOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$5367
P/E Ratio—
52W High$0.0001
52W Low$0.000001
Panacos Pharmaceuticals, Inc. (PANC) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · PANC · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2007-12 | 2006-12 | 2005-12 | 2004-12 | 2003-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.18M | $0.28M | $1.05M | $1.34M | $1.08M |
| Cost of Revenue | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Gross Profit | $0.18M | $0.28M | $1.05M | $1.34M | $1.08M |
| Gross Margin %(computed) | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| Operating Expenses | |||||
| R&D Expenses | $25.09M | $24.55M | $19.80M | $11.15M | $4.46M |
| G&A Expenses | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Total Operating Expenses | ($38.84M) | ($41.41M) | ($58.94M) | ($10.63M) | ($3.25M) |
| Operating Income | $39.02M | $41.70M | $59.98M | $11.97M | $4.33M |
| Operating Margin %(computed) | — | — | — | 895.21% | 401.76% |
| Interest Income | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Interest Expense | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Income Before Tax | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Income Tax Expense | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Net Income | ($37.46M) | ($38.11M) | ($59.08M) | ($12.04M) | ($4.51M) |
| Net Margin %(computed) | — | — | — | -900.37% | -418.18% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.70 | $-0.75 | $-1.72 | $-14.51 | $-2.74 |
| Wtd Avg Shares | 53.15M | 50.52M | 34.42M | 0.96M | 1.65M |
| EBITDA | ($38.23M) | ($40.94M) | ($39.94M) | ($11.74M) | ($4.19M) |
| EBITDA Margin %(computed) | — | — | — | -878.23% | -388.96% |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · USD · M
Explore more Panacos Pharmaceuticals, Inc. data
About Panacos Pharmaceuticals, Inc. (PANC) Income Statement
Panacos Pharmaceuticals, Inc. (PANC) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2007, PANC reported revenue of $0.00B, gross profit of $0.00B (gross margin 100.00%), and net income of ($0.04B) — a net profit margin of -20810.56%.
Frequently asked questions
PANC · 4 questionsPanacos Pharmaceuticals, Inc. (PANC) reported revenue of $0.00B for 2007, down 36.6% year-over-year.
PANC revenuePANC salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09